GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targeting Broad Spectrum Solid and Hematologic Malignancies Accepted for Presentation at ESMO IO Congress 2021

Stock Information for GT Biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.